Class 2 recall-Pharma Ltd, Clarithromycin 500 mg powder for concentrate for solution for infusion

Hameln Pharma Ltd is recalling the batches of Clarithromycin 500 mg powder for concentrate for solution for infusion listed in the table. Following an inspection of the clarithromycin lactobionate raw material manufacturer, the certification of suitability for use in medicines was withdrawn due to non-compliance with Good Manufacturing Practice.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-clarithromycin-500-mg-powder-for-concentrate-for-solution-for-infusion-el-25-a-slash-53?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a7aee035-dcbb-4a49-acb7-05dc0d52d0d7&utm_content=immediately

MHRA drug alert date: 11/12/25

Further Information

For all medical information enquiries and information on this product, please email drug.safety@hameln-pharma.co.uk or telephone +44 (0)1452 621 661.

For stock control enquiries please email customer.services@hameln-pharma.co.uk , or telephone +44 (0)1452 621 661.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 Caution In Use-Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets Flamingo Pharma

Flamingo Pharma UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the products listed in this notification do not contain all the required safety information.

MHRA drug alert Date: 10/12/25

MHRA drug alert link Class 4 Medicines Defect Notification: Flamingo Pharma UK Ltd, Amitriptyline Hydrochloride 10mg, 25mg, 50mg Tablets, EL(25)A/52 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email safety@flamingopharma.co.uk , or telephone +44 (0) 800 0668 348.

For stock control enquiries please email sales@flamingopharma.co.uk , or telephone +44 (0) 7784 240228.

Field safety notice-Stomahesive seal 48mm

This communication is to inform customers that Convatec is issuing a voluntary Field Correction Notice due to a
formatting discrepancy identified in the UDI barcode printed on the packaging of the products listed.

The barcode encoding on the secondary Market unit (sellable unit) places the Production Identifier (PI) before the
Device Identifier (DI), contrary to the expected UDI structure. This formatting may prevent the barcode from being
scanned correctly by some customer systems. The human-readable UDI text on the secondary Market unit (sellable
unit) remains accurate and complete. Note that the labelling on the products inside is also correct.

This is a caution in use only we are not accepting stock returns

further information

uk.customerservice@convatec.com

Christmas 2025 and New Year Opening Hours

To help keep our customers informed of changes to our service, we have published our Christmas 2025 and New Year bank holiday opening hours for pharmacy and retail customers.

Christmas 2025 bank holiday opening hours

Christmas 2025 bank holiday opening hours (for Channel Islands and Isle of Man)

Class 4 caution in use- Baclofen 10mg Tablets, Special Concept Development UK Limited

Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information.

MHRA drug alert Date: 27/11/25

MHRA drug alert link:Class 4 Medicines Defect Notification: Special Concept Development UK Limited, Baclofen 10mg Tablets, EL(25)A/51 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For medical information enquiries please email medinfo@rxfarma.co.uk or telephone 08003580163.

For supply chain inquiries please contact email supplychain@rxfarma.co.uk or telephone 01923 332 777.

Class 4 Caution in use-Moclobemide 150mg tablets

Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information.

MHRA drug alert Date: 25/11/25

MHRA drug alert link: Class 4 Medicines Defect Notification: Lexon UK Ltd, Moclobemide 150mg tablets, EL(25)A/50 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email QA@lexonuk.com, or telephone 01527 505 414. For stock control enquiries please email QA@lexonuk.com, or telephone 01527 505 414.

Class 3 recall- Fingolimod SUN 0.5mg hard capsules

CLASS 3 RECALL

Class 3 Recall from Sun Pharmaceutical Industries Limited

on Fingolimod SUN 0.5mg hard capsules

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-fingolimod-sun-0-dot-5mg-hard-capsules-el-25-a-slash-49?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=43ceb057-770e-45c5-b999-ad92df38ac1a&utm_content=immediately

MHRA ref: PL 31750/017

Reason: “Sun Pharma UK Limited is conducting a precautionary recall of a single batch of Fingolimod SUN 0.5 mg hard capsules due to reports of capsule breakage on removing from the blister. No other batches of Fingolimod SUN 0.5mg hard capsules are impacted.”

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050 / 07974754551.

For stock control enquiries please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Cencora Alliance Healthcare Raises Over £30,000 for Charities at annual Sports & Family Fun Day

Cencora Alliance Healthcare has raised over £30,000 for Cancer Research UK, Theodora Children’s Charity and Action Medical Research following its 2025 charity Sports Championship & Family Fun Day event.

Team members, friends and families joined the event located in Manchester and Wimbledon, to compete in competitive 5-a-side football tournaments and a charity netball match versus Theodora Children’s Charity.

Ellen Blessington, Communications Manager and Senior Fundraiser, Theodora Children’s Charity said: “We were delighted to once again be a part of this amazing event and play in the netball competition! Cencora Alliance Healthcare has supported the wellbeing of thousands of children living with illness by helping our Giggle Doctors bring music, magic, silliness and laughter to help improve children's hospital experience by reducing stress and anxiety and creating opportunities for play. Myself, along with Isabel from our Programme Team and Dr Fancy Pants had a fun filled day meeting all of the players, their families, and everyone that took part. Thank you so much for your kind support of our Giggle Doctors, Action Medical Research and Cancer Research UK, as we all work to help create healthier futures!”

Check out our 2025 Championship highlights video below 👇

Class 3 recall-Atorvastatin 20mg and 80mg Film-coated Tablet

Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-atorvastatin-20mg-and-80mg-film-coated-tablets-el-25-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=99643300-1345-488a-afc4-eb384dcbc1d6&utm_content=immediately

MHRA drug alert date 11/11/25

Further Information

For all medical information enquiries and information on this product, please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050 / 07974754551.

For stock control enquiries please email Cserv.uk@sunpharma.com, or telephone 020 8848 5050.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Emylif 50mg orodispersible film

Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-zambon-spa-emylif-50mg-orodispersible-film-el-25-a-slash-47

MHRA drug alert date 10/11/25

Further Information

For all medical information enquiries and information on this product, please email infoUK@zambongroup.com, or telephone + 44 (0)800 0288 942.

For stock control enquiries please email infoUK@zambongroup.com, or telephone + 44 (0)800 0288 942.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.